Sentence examples for both groups most AEs from inspiring English sources

In both groups, most AEs were surgery-related.

Rates of adverse events (AEs) were similar in both the colesevelam and placebo groups, and most AEs were unrelated to study treatment.

The rate of adverse events (AEs) was similar between the colesevelam and placebo groups, and most AEs were considered unrelated to the study medication (table 4).

After nasopharyngitis and headache, which were the most frequent AEs in both groups, the most common AEs in the EQW group were gastrointestinal-related, with spontaneously-reported nausea occurring in 18% of patients versus 2% in the detemir group (Table 2).

†>30 minutes post-vaccination Fisher's Exact test (p < 0.05 considered significant) ‡Temperature ≥37.5°C/99.5°F In both groups, the most frequent unsolicited AEs from Days 0 through Day 21 with TIV and placebo were pharyngolaryngeal pain (120/3783 and 120/3828, respectively [both 3%]), headache (118/3783 and 121/3828, respectively [both 3%]), and fatigue (108/3783 and 120/3828 [both 3%]).

The overall incidence of adverse events (AEs) in the laquinimod group was similar to the pooled placebo group (86.2% 96.7% vs 82.5%) and most AEs were mild to moderate in severity.

Most AEs could be grouped into the categories of 'stomach discomfort', 'nervousness' and 'dizziness'; other AEs were approximately equally distributed across the three treatment groups.

Most AEs in the vilazodone group were reported in week 1 of treatment.

The maximum severity of most AEs was assessed as mild or moderate in all dose groups.

Most AEs were mild to moderate in severity, although nine subjects in the colesevelam group and seven in the placebo group experienced a severe AE.

> -wrap-foot> Most AEs were grade 1 2 in severity, with neutropenia being the most commonly reported grade 3 4 AE in both the fosaprepitant and control groups (5.2% versus 4.8%).